Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | RECQL | P46063 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.33 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL440026 | 0.80 | ALDH1A1 (0.36) | CA12CA1CA9ALDH1A1KDM4E | |
| SCHEMBL317655 | 0.76 | ALB (0.49) | CA12CA1CA9ALDH1A1ALOX15 | |
| SCHEMBL4901236 | 0.73 | TLR9 (0.49) | CA12CA1CA9L3MBTL1ALDH1A1 | |
| SCHEMBL6006263 | 0.72 | TSHR (0.56) | L3MBTL1ALDH1A1KDM4EHPGDKMT2A | |
| SCHEMBL4565322 | 0.70 | ALDH1A1 (0.56) | CA12CA1CA9ALDH1A1ALOX15 | |
| SCHEMBL28755352 | 0.70 | TLR9 (0.45) | CA12CA1CA9L3MBTL1ALDH1A1 | |
| SCHEMBL3678196 | 0.70 | NPC1 (0.48) | CA12CA1CA9ALDH1A1ALOX15 | |
| SCHEMBL9262225 | 0.68 | GAA (0.55) | CA12CA1CA9L3MBTL1ALDH1A1 | |
| SCHEMBL15636976 | 0.68 | ALDH1A1 (0.43) | CA12CA1CA9L3MBTL1ALDH1A1 | |
| SCHEMBL11564833 | 0.68 | ALDH1A1 (0.43) | CA12CA1CA9L3MBTL1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11851383-B2 | Automatic process platform for the production of astatine-211 [At-211]-radiopharmaceuticals | ALPHA THERAPY SOLUTIONS AB (SE) | 2023-12-26 | — | — | US | disclosed |
| US-20210139389-A1 | AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [ AT 211] RADIOPHARMACEUTICALS | ATLEY SOLUTIONS AB (SE) | 2021-05-13 | — | — | US | disclosed |
| US-10829423-B2 | Automatic process platform for the production of astatine-211 [At 211] radiopharmaceuticals | ALPHA THERAPY SOLUTIONS AB (SE) | 2020-11-10 | — | — | US | disclosed |
| EP-3157577-B1 | AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS | LINDEGREN STURE (SE) | 2020-10-28 | — | — | EP | disclosed |
| US-20180215680-A1 | AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS | ATLEY SOLUTIONS AB (SE) | 2018-08-02 | — | — | US | disclosed |
| EP-3334453-A2 | ANTIBODY-BASED MOLECULES SPECIFIC FOR THE TRUNCATED ASP421 EPITOPE OF TAU AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY | New York University (US) | 2018-06-20 | — | — | EP | disclosed |
| EP-3166688-A1 | TAU IMAGING LIGANDS AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY | New York University (US) | 2017-05-17 | — | — | EP | disclosed |
| EP-3157577-A1 | AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS | Lindegren, Sture (SE) | 2017-04-26 | — | — | EP | disclosed |
| WO-2017027685-A2 | ANTIBODY-BASED MOLECULES SPECIFIC FOR THE TRUNCATED ASP421 EPITOPE OF TAU AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY | NEW YORK UNIVERSITY (US) | 2017-02-16 | — | — | WO | disclosed |
| WO-2016007414-A1 | TAU IMAGING LIGANDS AND THEIR USES IN THE DIAGNOSIS AND TREATMENT OF TAUOPATHY | NEW YORK UNIVERSITY (US) | 2016-01-14 | — | — | WO | disclosed |
| WO-2015195042-A1 | AUTOMATIC PROCESS PLATFORM FOR THE PRODUCTION OF ASTATINE-211 [At-211]-RADIOPHARMACEUTICALS | LINDEGREN STURE (SE) | 2015-12-23 | — | — | WO | disclosed |
| US-8097254-B2 | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis | EIDGENOSSISCHE TECHNISCHE HOCHSCHULE ZURICH (CH) | 2012-01-17 | — | — | US | disclosed |
| US-20060133994-A1 | Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis | NERI DARIO | 2006-06-22 | — | — | US | disclosed |
| EP-1259548-A1 | ANTIBODY SPECIFIC FOR THE ED-B DOMAIN OF FIBRONECTIN, CONJUGATES COMPRISING SAID ANTIBODY, AND THEIR USE FOR THE DETECTION AND TREATMENT OF ANGIOGENESIS | Eidgenössische Technische Hochschule Zürich (CH) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001062800-A1 | ANTIBODY SPECIFIC FOR THE ED-B DOMAIN OF FIBRONECTIN, CONJUGATES COMPRISING SAID ANTIBODY, AND THEIR USE FOR THE DETECTION AND TREATMENT OF ANGIOGENESIS | Eidgenössische Technische Hochschule Zürich (CH) | 2001-08-30 | — | — | WO | disclosed |